for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Top News

Breakingviews: Drugged up on M&A

Posted

July 1 - Richard Beales talks to Rob Cyran about Onyx’s search for a buyer and why the cancer drug maker was right to reject Amgen’s $10 bln hostile bid.

Top News

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up